方盛制药跌2.01%，成交额9891.70万元，主力资金净流出1363.76万元

Core Insights - The stock price of Fangsheng Pharmaceutical has decreased by 2.01% on September 9, trading at 11.21 CNY per share with a market capitalization of 4.922 billion CNY [1] - The company has experienced a year-to-date stock price increase of 10.33%, but has seen a decline of 2.94% over the last five trading days [1] Financial Performance - For the first half of 2025, Fangsheng Pharmaceutical reported a revenue of 834 million CNY, a year-on-year decrease of 8.35%, while the net profit attributable to shareholders increased by 23.67% to 169 million CNY [2] - Cumulative cash dividends since the company's A-share listing amount to 623 million CNY, with 418 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders has increased to 33,100, with an average of 13,245 circulating shares per shareholder, a slight decrease of 0.36% [2] - The top three circulating shareholders include ICBC Medical Health Stock, holding 5.3997 million shares, and Rongtong Health Industry Flexible Allocation Mixed Fund, which increased its holdings by 500,000 shares to 5 million [3]